Class 4 Medicines Defect Notification: Sandoz Limited, Co-Amoxiclav powder for oral suspension 250/62.5 mg/mL, EL(26)A/46
Imported from official source
Sandoz Limited have informed the MHRA of errors in the dosing table in the Summary of Product Characteristics (SmPC) for Co-amoxiclav 250/62.5 mg/5 ml Powder for Oral Suspension.
This version
- Version
- 1 of 1
- Recorded
- November 05, 2026 11:02
- Change
- Initial
- Content hash
c4605e40389e671c327e587d5a94dcad- All versions
- Revision history